United Therapeutics (UTHR) Current Leases (2010)

United Therapeutics' (UTHR) quarterly Current Leases came in at $31.2 million in Q3 2010, up 0.9% quarter-over-quarter from $30.9 million in Q2 2010.

United Therapeutics (UTHR) Current Leases (2010) Analysis & Trends

United Therapeutics has disclosed Current Leases across 1 years of filings, most recently posting $31.2 million for Q3 2010.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Current Leases (Qtr)
1 Teva Pharmaceutical Industries 38.34 Bn 34.60 Bn 1.97 Bn -
2 Zoetis 33.27 Bn 31.33 Bn 1.62 Bn -
3 United Therapeutics 23.75 Bn 21.60 Bn 648.10 Mn -
4 Aurora Cannabis 17.11 Bn 17.03 Bn 33.43 Mn 23.81 Mn
5 Neurocrine Biosciences 16.37 Bn 15.05 Bn 800.70 Mn -
6 Elanco Animal Health 11.78 Bn 11.35 Bn 785.00 Mn -
7 Alkermes 7.05 Bn 6.54 Bn -116.06 Mn 7.58 Mn
8 Lantheus Holdings 6.49 Bn 5.99 Bn 230.92 Mn -
9 Hims & Hers Health 6.19 Bn 5.44 Bn 396.79 Mn 5.58 Mn
10 Liquidia 5.63 Bn 5.40 Bn 121.79 Mn 807,000.00

Historic Data

Download Data
DateValue
Sep 30, 2010 31.15 Mn
Jun 30, 2010 30.88 Mn